Heilongjiang ZBD Pharmaceutical Co., Ltd.
SHH: 603567.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jiujiang Yan
- Employees
- 2,545
- Headquarters
- Hulin, China
- IPO year
- 2015
- Market cap
- CN¥6.8B
- Website
- https://www.zbdzy.com
Loading 603567…
Loading profile data…Frequently asked questions about 603567
What does Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) do?
Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is...
Where does 603567.SS trade?
Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) trades on the Shanghai Stock Exchange.
What sector is 603567.SS in?
Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Heilongjiang ZBD Pharmaceutical Co., Ltd.?
Jiujiang Yan is the chief executive officer of Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS).
Where is Heilongjiang ZBD Pharmaceutical Co., Ltd. headquartered?
Heilongjiang ZBD Pharmaceutical Co., Ltd. is headquartered in China.
Does 603567.SS pay a dividend?
Yes — Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) paid a trailing twelve-month dividend of CNY 0.15 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603567.SS go public?
Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) completed its initial public offering in 2015.